However, no correlation was seen between overall survival and STING expression in the immune cells (Fig. 6D, P = 0.085), suggesting intrinsic tumor expression of STING may be beneficial for antitumor responses (median survival for patients with high STING expression in immune cells = 97.5 months, low STING = 82 months). Here, STING1 is linked to neoplasm.